Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial ( <scp>BEGIN</scp> : <scp>ADD TO GLP</scp> ‐1 <scp>S</scp> tudy)

Abstract

The addition of liraglutide and IDeg to patients sub-optimally treated with metformin and liraglutide and requiring treatment intensification was found to be effective and well-tolerated.